Literature DB >> 22209974

Expression and prognosis of FOXO3a and HIF-1α in nasopharyngeal carcinoma.

Zhu Shou1, Li Lin, Jia Liang, Jing-Li Li, Hong-Yan Chen.   

Abstract

PURPOSE: The Forkhead Box O3a transcription factor (FOXO3a) and hypoxia-inducible factor-1α (HIF-1α) have been reported to play important roles in the development and prognosis of human cancers. However, their exact roles are not clear. Therefore, we investigated the expression status and clinical significance of FOXO3a and HIF-1α expression in nasopharyngeal carcinoma.
METHODS: The expression of FOXO3a and HIF-1α proteins was detected in nasopharyngeal carcinoma tissues and normal nasopharyngeal tissues by immunohistochemistry and western blot. Furthermore, we analyzed the association of FOXO3a and HIF-1α expression with various clinicopathologic factors including survival status of nasopharyngeal carcinoma patients.
RESULTS: FOXO3a was low expressed and HIF-1α was high expressed in nasopharyngeal carcinoma tissues, compared with normal nasopharyngeal tissues (both P < 0.05). The low expression of FOXO3a was significantly correlated with clinical stage (P = 0.003), T stage (P = 0.011), lymph node metastasis (P = 0.003), and distant metastasis (P = 0.030), and over expression of HIF-1α was significantly correlated with T stage (P = 0.026), lymph node metastasis (P = 0.002), and distant metastasis (P = 0.010). The Spearman analysis indicated that FOXO3a expression was inversely correlated with HIF-1α expression(rs = -0.598, P < 0.001). Overall survival curves estimated by Kaplan-Meier showed that tumor patients with low FOXO3a or high HIF-1α expression had significantly poorer prognosis compared with patients with high FOXO3a or low HIF-1α levels (P < 0.001, and P = 0.012, respectively). In addition, multivariate Cox regression analysis showed that T stage, distant metastasis, and FOXO3a were significant independent prognostic factors for overall survival (P = 0.011, P = 0.008, and P = 0.047, respectively).
CONCLUSIONS: Our results suggested that FOXO3a and HIF-1α may be considered to be important prognostic markers in nasopharyngeal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22209974     DOI: 10.1007/s00432-011-1125-7

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  32 in total

Review 1.  The many forks in FOXO's road.

Authors:  Hien Tran; Anne Brunet; Eric C Griffith; Michael E Greenberg
Journal:  Sci STKE       Date:  2003-03-04

2.  The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy.

Authors:  L H GRAY; A D CONGER; M EBERT; S HORNSEY; O C SCOTT
Journal:  Br J Radiol       Date:  1953-12       Impact factor: 3.039

3.  Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1.

Authors:  B H Jiang; G Jiang; J Z Zheng; Z Lu; T Hunter; P K Vogt
Journal:  Cell Growth Differ       Date:  2001-07

4.  Foxo3a suppression of urothelial cancer invasiveness through Twist1, Y-box-binding protein 1, and E-cadherin regulation.

Authors:  Masaki Shiota; YooHyun Song; Akira Yokomizo; Keijiro Kiyoshima; Yasuhiro Tada; Hiroshi Uchino; Takeshi Uchiumi; Junichi Inokuchi; Yoshinao Oda; Kentaro Kuroiwa; Katsunori Tatsugami; Seiji Naito
Journal:  Clin Cancer Res       Date:  2010-12-01       Impact factor: 12.531

5.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.

Authors:  D M Brizel; S P Scully; J M Harrelson; L J Layfield; J M Bean; L R Prosnitz; M W Dewhirst
Journal:  Cancer Res       Date:  1996-03-01       Impact factor: 12.701

6.  The expression and prognosis of FOXO3a and Skp2 in human hepatocellular carcinoma.

Authors:  Mudan Lu; Jianbo Ma; Wenqun Xue; Chun Cheng; You Wang; Yueming Zhao; Qing Ke; Haiou Liu; Yonghua Liu; Peng Li; Xiaopeng Cui; Song He; Aiguo Shen
Journal:  Pathol Oncol Res       Date:  2009-04-30       Impact factor: 3.201

7.  Deregulation of FOXO3A during prostate cancer progression.

Authors:  Sanjeev Shukla; Meenakshi Shukla; Gregory T Maclennan; Pingfu Fu; Sanjay Gupta
Journal:  Int J Oncol       Date:  2009-06       Impact factor: 5.650

8.  FOXO3a: a novel player in thyroid carcinogenesis?

Authors:  Stefan Karger; Carl Weidinger; Kerstin Krause; Sien-Yi Sheu; Thomas Aigner; Oliver Gimm; Kurt-Werner Schmid; Henning Dralle; Dagmar Fuhrer
Journal:  Endocr Relat Cancer       Date:  2008-10-09       Impact factor: 5.678

9.  p38alpha blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1alpha- to FoxO-dependent transcription.

Authors:  F Chiacchiera; A Matrone; E Ferrari; G Ingravallo; G Lo Sasso; S Murzilli; M Petruzzelli; L Salvatore; A Moschetta; C Simone
Journal:  Cell Death Differ       Date:  2009-04-03       Impact factor: 15.828

Review 10.  HIF-1alpha and cancer therapy.

Authors:  Mei Yee Koh; Taly R Spivak-Kroizman; Garth Powis
Journal:  Recent Results Cancer Res       Date:  2010
View more
  17 in total

1.  Expression of PIM-1 in salivary gland adenoid cystic carcinoma: Association with tumor progression and patients' prognosis.

Authors:  Xin Zhu; Yunfang Yu; Xiuxiu Hou; Jiajie Xu; Zhuo Tan; Xilin Nie; Zhiqiang Ling; Minghua Ge
Journal:  Oncol Lett       Date:  2017-11-14       Impact factor: 2.967

Review 2.  Regulation of Bim in Health and Disease.

Authors:  Ronit Vogt Sionov; Spiros A Vlahopoulos; Zvi Granot
Journal:  Oncotarget       Date:  2015-09-15

Review 3.  Combining antiangiogenic therapy and radiation in nasopharyngeal carcinoma.

Authors:  Zhuo Chen; Xin-Hua Xu
Journal:  Saudi Med J       Date:  2015-06       Impact factor: 1.484

Review 4.  Prognostic value of HIFs expression in head and neck cancer: a systematic review.

Authors:  Liang Gong; Wei Zhang; Jianding Zhou; Jie Lu; Hua Xiong; Xueli Shi; Jianqiang Chen
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

5.  Expression of HIF-1α and CAIX in nasopharyngeal carcinoma and their correlation with patients' prognosis.

Authors:  Yuhan Chen; Xianming Li; Shihai Wu; Gang Xu; Yayan Zhou; Long Gong; Zihuang Li; Dong Yang
Journal:  Med Oncol       Date:  2014-11-07       Impact factor: 3.064

6.  Nicotine promotes proliferation of human nasopharyngeal carcinoma cells by regulating α7AChR, ERK, HIF-1α and VEGF/PEDF signaling.

Authors:  Dingbo Shi; Wei Guo; Wangbin Chen; Lingyi Fu; Jingshu Wang; Yung Tian; Xiangsheng Xiao; Tiebang Kang; Wenlin Huang; Wuguo Deng
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

Review 7.  Emerging themes from EBV and KSHV microRNA targets.

Authors:  Dhivya Ramalingam; Philippe Kieffer-Kwon; Joseph M Ziegelbauer
Journal:  Viruses       Date:  2012-09-21       Impact factor: 5.048

8.  Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.

Authors:  Guang-Da Yang; Tie-Jun Huang; Li-Xia Peng; Chang-Fu Yang; Ran-Yi Liu; Hong-Bing Huang; Qiao-Qiao Chu; Hong-Jie Yang; Jia-Ling Huang; Zhen-Yu Zhu; Chao-Nan Qian; Bi-Jun Huang
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

9.  Extracellular signal-regulated kinase signaling-mediated induction and interaction of FOXO3a and p53 contribute to the inhibition of nasopharyngeal carcinoma cell growth by curcumin.

Authors:  Jingjing Wu; Qin Tang; Shunyu Zhao; Fang Zheng; Yan Wu; Ge Tang; Swei Sunny Hahn
Journal:  Int J Oncol       Date:  2014-05-06       Impact factor: 5.650

10.  Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo.

Authors:  Yan Huang; Ying Tian; Yuanyuan Zhao; Cong Xue; Jianhua Zhan; Lin Liu; Xiaobo He; Li Zhang
Journal:  Cancer Commun (Lond)       Date:  2018-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.